Search - tctmd.com

Displaying 61 - 80 of 541

Sort: Relevancy | Date

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Daily News

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

L.A. McKeown

October 09, 2024

News Daily News

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

L.A. McKeown

October 01, 2024

News Conference News ESC 2024

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

Caitlin E. Cox

August 31, 2024

News Conference News ESC 2024

Polypills Show Promise in Diverse Hypertensive Patient Groups

L.A. McKeown

August 31, 2024

News Daily News

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Yael L. Maxwell

August 16, 2024

News Daily News

Obstacles Abound for Treating Severe BP: Some Clues for Care Lie in EHRs

Caitlin E. Cox

August 08, 2024

News Daily News

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

Michael O'Riordan

August 02, 2024

News Daily News

Semaglutide May Ease Tobacco Use, Study Suggests

Todd Neale

August 01, 2024

News Daily News

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Michael O'Riordan

July 29, 2024

News Daily News

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Michael O'Riordan

July 09, 2024

News Daily News

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Michael O'Riordan

June 28, 2024

News Daily News

‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD

Todd Neale

June 27, 2024

News Daily News

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

Michael O'Riordan

June 24, 2024

News Daily News

RAISE: Reteplase May Be Another Option for Stroke Thrombolysis

Todd Neale

June 20, 2024

News Daily News

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

L.A. McKeown

June 18, 2024

News Daily News

Don’t Worry About Muscle Loss With GLP-1 Inhibitors, Viewpoint Asserts

Yael L. Maxwell

June 10, 2024

News Daily News

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

Michael O'Riordan

June 04, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Michael O'Riordan

May 30, 2024

Advertisement

Will Semaglutide Change Cardiac Surgery? It Already Has

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

Polypills Show Promise in Diverse Hypertensive Patient Groups

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Obstacles Abound for Treating Severe BP: Some Clues for Care Lie in EHRs

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

Semaglutide May Ease Tobacco Use, Study Suggests

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Think You Need a Statin? AHA’s Risk Calculator May Disagree

‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

RAISE: Reteplase May Be Another Option for Stroke Thrombolysis

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

Don’t Worry About Muscle Loss With GLP-1 Inhibitors, Viewpoint Asserts

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

June 2024 Dispatch for the CV Team

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content